Welcome to our dedicated page for Blackrock Health Sciences Trust news (Ticker: BME), a resource for investors and traders seeking the latest updates and insights on Blackrock Health Sciences Trust stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Blackrock Health Sciences Trust's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Blackrock Health Sciences Trust's position in the market.
BlackRock (NYSE:BLK) has announced that its Board of Directors has declared a quarterly cash dividend of $5.10 per share of common stock. The dividend will be payable on December 23, 2024, to shareholders of record at the close of business on December 5, 2024.
BlackRock closed-end funds announced final results of their tender offers for up to 2.5% of outstanding common shares. The tender offers, which expired on November 18, 2024, were oversubscribed for each fund. As a result, shares will be purchased from tendering shareholders on a pro rata basis. For BlackRock Health Sciences Term Trust (BMEZ), 21,043,412 shares were tendered, with 2,596,285 to be purchased at $16.3856 per share. The purchase price equals 98% of each fund's NAV as of November 19, 2024. Payments are expected within five business days after expiration.
BlackRock (NYSE: BLK) has elected Bayo Ogunlesi to its Board of Directors as a non-independent director following BlackRock's acquisition of Global Infrastructure Partners (GIP) in October 2024. Ogunlesi, the Founding Partner, Chairman and CEO of GIP, joins as a Senior Managing Director at BlackRock. With this appointment, BlackRock's Board will comprise 17 members, including 14 independent directors. Prior to founding GIP in 2006, Ogunlesi spent 23 years at Credit Suisse in various senior positions, including Executive Vice Chairman and Chief Client Officer of its Investment Banking Division.
BlackRock has converted its International Dividend Fund into an active ETF, launching the BlackRock International Dividend ETF (NYSE:BIDD). This marks the firm's first active mutual fund to ETF conversion and first U.S.-listed active ETF focusing on high-quality dividend-paying companies across international developed and emerging markets. The ETF, managed by an all-female portfolio management team led by Olivia Treharne and Molly Greenen, aims to invest at least 80% of its net assets in dividend-paying international companies. BIDD has an expense ratio of 0.61% and tracks the MSCI ACWI ex US Index.
KBRA has assigned a BBB- rating with a Stable Outlook to BlackRock Private Credit Fund's $125 million senior unsecured notes. The notes include a $70 million tranche at 7.14% due 2027 and a $55 million tranche at 7.33% due 2030. The rating is supported by BlackRock's $10.5 trillion AUM platform and $65 billion private debt platform. The fund's portfolio consists of 99.9% senior secured first lien loans focused on core middle market companies. As of Q3 2024, the fund maintained low non-accruals (0.01% at FV), gross leverage of 0.41x, and solid asset coverage at 307%.
GeoWealth, iCapital, and BlackRock (NYSE: BLK) have announced a strategic partnership to enhance unified managed accounts (UMAs) with private assets integration. The collaboration enables registered investment advisors (RIAs) to access BlackRock's custom model portfolios through GeoWealth's platform, featuring private markets, direct indexing, and fixed income SMAs alongside traditional ETFs and mutual funds. The integration leverages iCapital's Multi-Investment Workflow Tool to streamline alternative assets investing, offering unified trade orders, automated processes, and consolidated client communications.
BlackRock's 13th annual Global Insurance Report reveals that 91% of insurers plan to increase investments in private assets over the next two years. The survey, covering 410 insurance investors across 32 markets, highlights key trends for 2024:
1. Increased focus on private markets, with 96% of APAC and North American insurers planning to boost allocations.
2. Clean energy infrastructure investments targeted by 60% of insurers for low-carbon transition objectives.
3. Emphasis on technology for private asset modeling (53%) and regulatory capital integration (51%).
Despite concerns about regulatory developments (68%) and geopolitical tensions (61%), 74% of insurers have no plans to change their current risk profiles. In public markets, 42% plan to increase allocations to government and agency bonds, while in private markets, there's growing interest in various forms of private debt.
BlackRock, Inc. (NYSE: BLK) has released its financial results for the third quarter of 2024. The company's earnings release and supplemental materials are available on their investor relations website. A teleconference call for investors and analysts will be hosted by Chairman and CEO Laurence D. Fink, President Robert S. Kapito, and CFO Martin S. Small at 7:30 a.m. ET.
Interested participants can dial in from the United States at (786) 460-7166 or from outside the US at (888) 600-4862, referencing the BlackRock Conference Call (ID Number 3678546). A live, listen-only webcast will also be available on BlackRock's website. The webcast replay will be accessible by 10:30 a.m. ET on Friday, October 11, 2024, through the investor relations section of BlackRock's website.
FAQ
What is the current stock price of Blackrock Health Sciences Trust (BME)?